New delivery systems to improve the bioavailability of resveratrol.
about
Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progressResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceCurcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerNutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjectureRole of dietary polyphenols in the management of peptic ulcerDietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice.Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cellsStabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation InhibitionIdentification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase.Future directions in the prevention of prostate cancer.Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy.Resveratrol, Potential Therapeutic Interest in Joint Disorders: A Critical Narrative Review.Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol.New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assemblies.Gastroretentive systems - a proposed strategy to modulate anthocyanin release and absorption for the management of diabetes.Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro.Cross-linked poly(acrylic acids) microgels and agarose as semi-interpenetrating networks for resveratrol release.mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer.Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.Anticancer Activity of Stilbene-Based Derivatives.Modulation of bacterial ghosts--induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol.Enhanced anti-inflammatory effect of resveratrol and EPA in treated endotoxin-activated RAW 264.7 macrophages.Implications of peptide assemblies in amyloid diseases.Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures.Polycaprolactone scaffold engineered for sustained release of resveratrol: therapeutic enhancement in bone tissue engineering.Trans-resveratrol-loaded nonionic lamellar liquid-crystalline systems: structural, rheological, mechanical, textural, and bioadhesive characterization and evaluation of in vivo anti-inflammatory activity.Alternaria sp. MG1, a resveratrol-producing fungus: isolation, identification, and optimal cultivation conditions for resveratrol production.Resveratrol Can Be Stable in a Medium Containing Fetal Bovine Serum with Pyruvate but Shortens the Lifespan of Human Fibroblastic Hs68 Cells.
P2860
Q21284734-F3CD23B4-5116-4C91-960B-64A55AD75FB5Q24618313-12F6AB9F-B3C4-4E60-96A6-A9CC0F06D35DQ26744566-0E30647D-D58D-4F09-BC3F-535F7588DFF0Q28072269-34BDFB9A-6A8E-402A-BEA4-A8B9219F2BC0Q28088459-91463462-1137-4FDD-8536-DC0374D7F8C2Q34539310-0BC4617D-EE25-4CCC-8A61-8A7780F9A013Q35758033-EAB87576-CE6A-40C9-B581-5441341B5F0BQ36499539-CEF30497-1017-45BD-B8AD-907BAA0B06A6Q36744202-727CA84D-3BE0-4B25-AE7B-C269924FDED3Q37279094-F0404F9F-A1E3-41F8-83E7-A21CB921F314Q37403020-2BB449FE-571B-440D-AC39-775F152E6C6EQ37628401-87933DD5-8367-4708-B031-952E71901EC4Q38121603-036D5E1E-0ADF-4827-BB00-EAF37C97B24CQ38424828-29AB2270-5F73-45B8-B2DB-44B7AB8BB3F9Q38731656-4CD74294-CC5C-4987-B515-E81697D849C4Q38744248-7C30B230-1D0E-4D9C-AB91-8BED71D6DA49Q38921280-23455B38-A8EA-4C63-85EA-BD042FCCFB3CQ38940855-96FF7C25-A68C-4A54-A6C8-5050E20DD308Q39103076-85941843-97AB-4B29-94FB-7DA01B623359Q39165544-072B4A6B-38AB-4470-A7E1-EE14D051AC48Q39216390-817F22B8-E251-4A0E-898E-0F809E8C7139Q39417166-AB71A926-9803-4DF3-A99B-863A7F2979AFQ39431937-21B59385-0927-48D6-8C14-31B98E7E8B9CQ39488935-8F74628D-C7A1-4F98-A0B2-D56B05C02266Q41451335-8810A341-BEE2-492F-9EBB-24FDA5488241Q41960585-D5A9F7B4-3C65-4E89-8669-ED415B884360Q42735998-C391EEAD-CBAD-493F-8B7E-0AB6E29B0BDBQ48050315-280D8D34-803A-4CAA-9696-6C575F69CFF7Q55092838-CF10F82A-8A83-4BF1-A4BB-9EABD15EE126
P2860
New delivery systems to improve the bioavailability of resveratrol.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
New delivery systems to improve the bioavailability of resveratrol.
@ast
New delivery systems to improve the bioavailability of resveratrol.
@en
New delivery systems to improve the bioavailability of resveratrol.
@nl
type
label
New delivery systems to improve the bioavailability of resveratrol.
@ast
New delivery systems to improve the bioavailability of resveratrol.
@en
New delivery systems to improve the bioavailability of resveratrol.
@nl
prefLabel
New delivery systems to improve the bioavailability of resveratrol.
@ast
New delivery systems to improve the bioavailability of resveratrol.
@en
New delivery systems to improve the bioavailability of resveratrol.
@nl
P2860
P50
P1476
New delivery systems to improve the bioavailability of resveratrol
@en
P2093
Ana Cláudia Santos
António J Ribeiro
P2860
P304
P356
10.1517/17425247.2011.581655
P407
P577
2011-06-14T00:00:00Z